Sabril (For Oral Solution)

Role

Indications

Reactions

Primary

Product Used For Unknown Indication	55.7%
Infantile Spasms	27.1%
Epilepsy	5.4%
Convulsion	4.1%
Complex Partial Seizures	3.1%
Grand Mal Convulsion	1.1%
Tuberous Sclerosis	0.7%
Pain	0.4%
Constipation	0.3%
Tonic Convulsion	0.3%
Partial Seizures	0.3%
Pyrexia	0.3%
Aicardi's Syndrome	0.2%
Early Infantile Epileptic Encephalopathy With Burst-suppression	0.2%
Wheezing	0.2%
Dyspnoea	0.1%
Gastrooesophageal Reflux Disease	0.1%
Generalised Non-convulsive Epilepsy	0.1%
Simple Partial Seizures	0.1%
Status Epilepticus	0.1%

Convulsion	24.7%
Drug Ineffective	17.6%
Hospitalisation	8.2%
Drug Dose Omission	8.1%
Pneumonia	7.1%
Death	4.1%
Vomiting	4.1%
Infantile Spasms	3.7%
Somnolence	3.7%
Pyrexia	2.4%
Nuclear Magnetic Resonance Imaging Brain Abnormal	2.1%
Status Epilepticus	2.1%
Incorrect Dose Administered	1.9%
Irritability	1.7%
Muscle Spasms	1.5%
Nasopharyngitis	1.5%
Psychomotor Hyperactivity	1.5%
Tremor	1.3%
Upper Respiratory Tract Infection	1.3%
Viral Infection	1.3%

Secondary

Product Used For Unknown Indication	51.4%
Infantile Spasms	24.3%
Epilepsy	7.2%
Convulsion	5.4%
Complex Partial Seizures	3.5%
Grand Mal Convulsion	1.4%
Tonic Convulsion	0.8%
Tuberous Sclerosis	0.8%
Gastrooesophageal Reflux Disease	0.7%
Partial Seizures	0.6%
Aicardi's Syndrome	0.6%
Early Infantile Epileptic Encephalopathy With Burst-suppression	0.6%
Constipation	0.5%
Pain	0.5%
Status Epilepticus	0.4%
Wheezing	0.3%
Dyspnoea	0.3%
Pyrexia	0.3%
Prophylaxis Against Gastrointestinal Ulcer	0.2%
Ear Infection	0.2%

Convulsion	31.2%
Drug Ineffective	17.1%
Hospitalisation	6.8%
Death	5.9%
Pneumonia	5.3%
Vomiting	4.2%
Somnolence	3.5%
Nuclear Magnetic Resonance Imaging Brain Abnormal	3.1%
Drug Dose Omission	2.9%
Infantile Spasms	2.9%
Weight Increased	2.2%
Psychomotor Hyperactivity	2.0%
Respiratory Failure	2.0%
Muscle Spasms	1.8%
Pyrexia	1.8%
Viral Infection	1.8%
Status Epilepticus	1.5%
Urinary Tract Infection	1.5%
Irritability	1.3%
Retinal Disorder	1.3%